Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2025-12-25 @ 2:39 PM
NCT ID: NCT01221350
Description: Serious or Other (non-serious) Adverse Events were collected/assessed, but none were observed during the 60 days period of intervention.
Frequency Threshold: 5
Time Frame: 60 days
Study: NCT01221350
Study Brief: Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lipoic Acid Lipoic acid 600 mg dose (two 300 mg capsules, p.o) once daily in the morning None None 0 23 0 23 View
Placebo Placebo 600 mg vehicle (two 300 mg capsules, p.o) once daily in the morning None None 0 24 0 24 View
Serious Events(If Any):
Other Events(If Any):